RecruitingNCT05873387
Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope
Deep Learning for Algorithmic Detection of Pulmonary Hypertension Using a Combined Digital Stethoscope and Single-lead Electrocardiogram
Sponsor
Eko Devices, Inc.
Enrollment
2,420 participants
Start Date
Jul 12, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
The major goal of the study is to determine whether phonocardiography (using the Eko DUO stethoscope which can capture a three lead ECG reading) can present features that relate to the presence of PH diagnosed by echocardiography or right heart catheterization (RHC), and therefore have a potential to assist the provider to suspect PH.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- Patients, ages \>18 years, referred for complete 2-dimensional echocardiography or right heart catheterization will be screened for inclusion.
Exclusion Criteria2
- Patients undergoing limited echocardiography
- Intubated patients
Interventions
DEVICEUse of Eko DUO stethoscope (paired ECG/PCG)
Auscultation of heart sounds using electronic stethoscope
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05873387
Related Trials
A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489
NCT0707382036 locations
Development of Novel Physiological CMR Methods in Health and Disease
NCT038540711 location
Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders
NCT074771971 location
Natural History Study of Biomarkers in Pulmonary Arterial Hypertension
NCT017300921 location
Preliminary Human Trials of F230 Tablets
NCT068998151 location